Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2012
03/01/2012WO2012027731A2 Pharmaceutical composition and administrations thereof
03/01/2012WO2012027711A2 Compositions and methods for treating bone defects
03/01/2012WO2012027514A2 Compositions and methods for cardiac therapy
03/01/2012WO2012027455A1 Glutathione-lanthionine compounds and methods related thereto
03/01/2012WO2012027411A2 Compositions and uses of materials with high antimicrobial activity and low toxicity
03/01/2012WO2012027378A2 Particles for drug delivery and other applications
03/01/2012WO2012027365A2 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/01/2012WO2012027247A2 Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof
03/01/2012WO2012027222A1 Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
03/01/2012WO2012026908A2 Cefpodoxime proxetil formulations comprising taste regulating agent
03/01/2012WO2012026907A2 Cefpodoxime proxetil formulations
03/01/2012WO2012026904A1 A single unit dosage form on the basis of a combination comprising donepezil and ginkgo biloba extract
03/01/2012WO2012026903A1 Synergistic compositions comprising memantine and gingko - biloba extract
03/01/2012WO2012026896A1 Surface modified micronized tacrolimus crystalline particles and pharmaceutical compositions thereof
03/01/2012WO2012026829A1 Transdermal patch
03/01/2012WO2012026711A2 Composite powder of titanium dioxide and mica, and makeup cosmetic composition containing same
03/01/2012WO2012026609A1 Aqueous composition for ophthalmic administration
03/01/2012WO2012026608A1 Polymeric particle and hydrophilic dye having a sulfonate group encapsulated within the particle
03/01/2012WO2012026562A1 Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
03/01/2012WO2012026533A1 Hydrogel laminate, method for producing hydrogel laminate, and hydrogel
03/01/2012WO2012026468A1 Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles
03/01/2012WO2012026316A1 Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same
03/01/2012WO2012025921A1 Compositions for gastric delivery of active agents
03/01/2012WO2012025730A2 Soluble film
03/01/2012WO2012025677A1 Inhalable gaseous drug containing krypton for treating neuro-intoxication
03/01/2012WO2012025624A1 Processes for producing microporous silica materials
03/01/2012WO2012025553A1 Particulate biologic drug delivery system with a controlled dual release
03/01/2012WO2012025551A1 Porous degradable polyelectrolyte microspheres as vaccine vector
03/01/2012WO2012025496A1 Humidified particles comprising a therapeutically active substance
03/01/2012WO2012024785A1 Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions
03/01/2012WO2012024784A1 Cell-protective peptides and uses thereof
03/01/2012WO2012024767A1 Improved enteric active substance delivery
03/01/2012WO2011163328A8 Methods for producing tissue scaffold directing differentiation of seeded cells and tissue scaffolds produced thereby
03/01/2012WO2011163206A3 Controlled release compositions with reduced food effect
03/01/2012WO2011161531A4 Pharmaceutical composition containing goserelin for in-situ implant
03/01/2012WO2011161254A3 Swellable substance actuator with an electrically driven fluidic transportation device
03/01/2012WO2011161056A3 Dialysis precursor composition
03/01/2012WO2011151704A3 Stable pharmaceutical compositions of rapamycin esters
03/01/2012WO2011144745A3 Improved liposomal formulations of lipophilic compounds
03/01/2012WO2011143271A3 Therapeutic liposomes and methods for producing and using the same
03/01/2012WO2011140236A3 Triamcinolone acetonide formulations for treating dermatitis and psoriasis
03/01/2012WO2011140128A3 Nail discoloration and fungus treatment
03/01/2012WO2011140126A3 Nail discoloration and fungus treatment
03/01/2012WO2011139252A3 Efervescent formulations comprising cefdinir
03/01/2012WO2011139250A3 Water dispersible formulation comprising betahistine
03/01/2012WO2011139249A3 Pharmaceutical composition comprising cefdinir
03/01/2012WO2011139044A3 Controlled-release pharmaceutical composition including tamsulosin or the pharmaceutically acceptable salts thereof, and oral preparation including same
03/01/2012WO2011137456A9 Methods and mechanisms involving hyperpigmentation particularly for african american skin
03/01/2012WO2011137228A3 Composition and method for treating eustachian tube dysfunction
03/01/2012WO2011135461A3 Clay compositions
03/01/2012WO2011125015A3 Protease-activatable pore-forming polypeptides
03/01/2012WO2011111027A3 Oral dispersible delayed release tablet formulation
03/01/2012WO2011109809A3 A novel composition of matter for delivering lipid-soluble materials, and a method for producing it
03/01/2012WO2011109334A3 Localization of agents at a target site with a composition and an energy source
03/01/2012WO2011108826A3 Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof
03/01/2012WO2011106416A3 Abuse-resistant formulations
03/01/2012WO2011098518A3 Delivery of immunoglobulin variable domains and constructs thereof
03/01/2012WO2011095801A3 Liquid pharmaceutical composition for buccal administration comprising morphine
03/01/2012WO2011093814A3 A pharmaceutical combination comprising formoterol and ciclesonide
03/01/2012WO2011076208A3 Calcipotriol monohydrate nanocrystals
03/01/2012WO2011076207A3 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
03/01/2012WO2011064271A3 Use of an oleo gel containing triterpene for healing wounds
03/01/2012WO2011059324A4 Composition for topical application, uses thereof, applicator device and kit of parts
03/01/2012WO2011053989A3 Process of transfection of mutagenic and recombinant nucleic acids to cells by polymeric materials loaded therewith
03/01/2012WO2011053265A3 The parmaceutical compositions comprising calcium and vitamin d
03/01/2012WO2011051354A3 Transdermal pharmaceutical compositions comprising active agents
03/01/2012WO2011042077A8 Transdermal therapeutic systems containing 4-n-butylresorcinol
03/01/2012US20120053692 Compositions and methods for treating bone defects
03/01/2012US20120053619 Hemostatic compositions and methods of making and using same
03/01/2012US20120053451 Methods and systems for prolonged localization of drug delivery
03/01/2012US20120053239 Treatment for intestinal gas, bloating, microscopic colitis, inflammatory bowel disease and traveler's diarrhea using colloidal bismuth subcitrate
03/01/2012US20120053219 Processes of making and using pharmaceutical formulations of antineoplastic agents
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
03/01/2012US20120053145 Aripiprazole complex formulation and method
03/01/2012US20120053058 Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation
03/01/2012US20120052292 Novel medical device coatings
03/01/2012US20120052128 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
03/01/2012US20120052127 Expanded polystyrene particles having skin layer with superior moldability, method for preparing the same and expanded polystyrene molded article using the same
03/01/2012US20120052126 Nanoemulsions Containing Antioxidants And Other Health-Promoting Compounds
03/01/2012US20120052125 Cholesteryl Sulfate-Containing Composition As A Haemostatic
03/01/2012US20120052124 Silk fibroin systems for antibiotic delivery
03/01/2012US20120052123 Silyl ether-modified hydrophilic polymers and uses for medical articles
03/01/2012US20120052122 Treatment Of Chronic Obstructive Pulmonary Disease With Phosphodiesterase-4 Inhibitor
03/01/2012US20120052121 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
03/01/2012US20120052120 Nanotechnology formulation of poorly soluble compounds
03/01/2012US20120052119 Nanoencapsulated delta-9-tetrahydrocannabinol
03/01/2012US20120052118 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
03/01/2012US20120052117 Soft capsule of butylphthalide and a process for preparing the same
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052115 Nanocarrier therapy for treating invasive tumors
03/01/2012US20120052114 Apparatus and methods for making nanosomes loaded with nucleic acid
03/01/2012US20120052113 Transdermal preparation
03/01/2012US20120052112 Risperidone-containing transdermal preparation and adhesive patch using same
03/01/2012US20120052111 Adhesive Laminates for Rapid Wound Occlusion
03/01/2012US20120052108 Macrocyclic lactone drug delivery system
03/01/2012US20120052105 Nanostructural composition of biocide and process of obtaining nanostructural biocide nanocomposition
03/01/2012US20120052101 Thin film strips
03/01/2012US20120052099 Pharmaceutical composition containing arbidol in the form of phospholipid nanoparticles
03/01/2012US20120052098 Liquid ganaxolone formulations and methods for the making and use thereof
03/01/2012US20120052097 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 2991